Short sellers found fresh targets this week. The most dramatic move came from BDRX. Biodexa Pharmaceuticals saw its SI % of Free Float rocket to 1,771% — up from 112% just seven days ago. That extraordinary figure reflects heavy borrowing against a tiny float. Cost to borrow sits at 503%. Zero shares remain available to borrow.
The EV space is also drawing attention. XPEV hit a utilization rate of 98.47%, near its 52-week high of 100%. That means almost every lendable share is already out on loan. With only 2.3% availability of SI remaining, new short positions are nearly impossible to open without squeezing existing holders.
SOUN keeps drawing bears too. SoundHound AI sits at 37.5% SI of FF with zero borrowable shares left. Cost to borrow is 22%. Any positive catalyst here could ignite a sharp squeeze.
Among the meme favourites, GME ticked up slightly to 14.8% SI of FF. AMC moved the other way — dropping nearly week-on-week to 12.2%, suggesting some shorts are exiting.
Not financial advice. Short interest data from ORTEX as of May 7, 2026.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.